ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 61 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q4 2022. The put-call ratio across all filers is 0.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $508,800 | -90.4% | 320,000 | -94.3% | 0.06% | -92.1% |
| Q3 2022 | $5,308,000 | +438.3% | 5,587,789 | +5488.2% | 0.72% | +305.1% |
| Q1 2021 | $986,000 | -33.1% | 99,992 | -26.5% | 0.18% | -8.2% |
| Q4 2020 | $1,474,000 | -60.7% | 135,992 | -62.7% | 0.19% | -90.2% |
| Q3 2020 | $3,753,000 | -17.8% | 364,349 | +66.6% | 1.99% | -23.6% |
| Q2 2020 | $4,566,000 | +48.9% | 218,723 | -30.3% | 2.60% | -27.1% |
| Q1 2020 | $3,067,000 | -22.3% | 313,900 | -8.4% | 3.57% | -6.3% |
| Q4 2019 | $3,949,000 | – | 342,800 | – | 3.81% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonic Fund II, L.P. | 6,552,068 | $14,218,000 | 8.03% |
| Versant Venture Management, LLC | 5,068,233 | $10,998,000 | 4.55% |
| K2 PRINCIPAL FUND, L.P. | 1,653,874 | $3,589,000 | 0.29% |
| RTW INVESTMENTS, LP | 7,483,757 | $16,240,000 | 0.24% |
| Avoro Capital Advisors LLC | 6,950,000 | $15,082,000 | 0.24% |
| Artal Group S.A. | 3,000,000 | $6,510,000 | 0.15% |
| ALGERT GLOBAL LLC | 231,490 | $502,000 | 0.07% |
| Virtus ETF Advisers LLC | 57,768 | $125,000 | 0.06% |
| Pinz Capital Management, LP | 53,600 | $116,000 | 0.05% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 100,000 | $217,000 | 0.05% |